Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
adverse, Agency, aim, ancillary, antigen, AREXVY, arise, began, bevacizumab, biopharmaceutical, BLA, blocking, cap, Certificate, CUSIP, customary, cytotoxic, death, defense, Delaware, discover, Eastern, equal, exceed, flow, footnote, founding, heavily, higher, human, hurdle, ImmunoScape, Incorporated, Incorporation, incremental, indemnification, IPO, Kettering, library, Ligand, litigation, maturing, maximum, mCRC, Memorial, multifunctional, neoadjuvant, NLM, notably, occurrence, ordinary, outcome, ovarian, payable, pembrolizumab, permitted, POS, POSASR, pretreated, pro, proposal, pursuing, randomized, rapid, RAS, rata, ratio, realization, receptor, reflect, repayment, retroactively, reverse, RSV, runway, Secretary, security, segment, Sloan, split, submission, synthetic, tax, ticker, underway, unique, warrant, wild
Removed:
American, assignment, calculate, charge, checkpoint, combined, cover, CPM, data, engineered, enrolled, external, failure, Franc, implied, initiated, joint, KEYTRUDA, managed, mechanically, melanoma, microsatellite, older, oncology, OPDIVO, pancreatic, remaining, requirement, stable, steering, survival, Switzerland, technology, Treasury, unit, unmodified, unsatisfied, ventilated, withheld
Filing tables
Filing exhibits
Associated AGEN transcripts
AGEN similar filings
Filing view
External links